Stealth Granted Pre-NDA Meeting For Elamipretide To Treat Barth Syndrome

Stealth BioTherapeutics To Be Taken Private In All-cash Deal

Biotechnology company Stealth BioTherapeutics Corp (MITO) announced Monday that it has entered into a definitive Agreement and Plan of Merger with Stealth Parent Limited,, and Stealth Merger Sub Limited, a wholly-owned subsidiary of Parent, to be acquired by a consortium of investors led by Morningside Venture (I) Investments Ltd. and J. Wood Capital Advisors LLC in an all-cash transaction.

RTTNews | 1159 hari yang lalu

Bay Street Headed For Positive Start

Higher Canadian and U.S. futures and firm commodity prices point to a positive start for the Canadian market Friday morning. Optimism surrounding artificial intelligence and expectations of a rate cut by the Federal Reserve may help underpin sentiment.

RTTNews | 13 minit yang lalu

FTSE 100 Up Firmly In Positive Territory, Set To End Week On Strong Note

The U.K. stock market is up in positive territory Friday afternoon, supported by gains in banking and mining sectors. The benchmark FTSE 100 is well set to end the week with a gain of about 2%.

RTTNews | 53 minit yang lalu

CAC 40 Roughly Flat As Investors Focus On Economic Data

The French stock market is roughly flat Friday afternoon with stocks turning in a mixed performance as investors react to the latest batch of regional economic data, and continuing to assess the impact of the government shutdown in the U.S.

RTTNews | 1j 22min yang lalu

DAX Down Marginally, But Stays On Course For Strong Weekly Gain

German stocks are turning in a mixed performance on Friday, but remain well on course to record their strongest week in over five months. Optimism surrounding artificial intelligence and expectations of a rate cut by the Federal Reserve help underpin sentiment.

RTTNews | 1j 49min yang lalu